Genesco raised its sales and earnings guidance for its 2025 fiscal year, as the turnaround of its Journeys division accelerates, offsetting softer demand and a more cautious outlook for its Schuh and Johnston & Murphy businesses.
Your membership benefits:
To continue reading this article REGISTER NOW.